Complexation studies on inositol-phosphates: IV. Ca(II) complexes of myo-inositol 1,4,5-trisphosphate

https://doi.org/10.1016/0162-0134(92)84036-MGet rights and content

Abstract

The stability constants of the complexes formed between Ca2+ and the myo-inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) were determined by potentiometric titration in two different media and temperature conditions (medium 1: I = 0.1 M But4NBr, 25°C; medium 2: I = 0.2 M KCl, 37°C). Mainly because of the presence of potassium the results obtained in these media show large differences in both the nature and the stability of the complexes. In medium 1, MH2L and M2L species are formed along with the ML and MHL species which also exist in medium 2. In addition, the stability of the latter species decreases by more than one log unit in going from medium 1 to medium 2. In an attempt to assess the biological significance of the metal binding to Ins(1,4,5)P3, the results were compared to the Ca2+-ATP complexes that form in the same media conditions. Taking into account the relative stability of the complexes of both systems, it is likely that the action or metabolism of Ins(1,4,5)P3 may be influenced by coordination of either alkali or alkali-earth cations.

References (19)

  • S.R. Nahorski et al.

    Trends Pharmacol. Sci.

    (1986)
  • P.F. Worley et al.

    J. Biol. Chem.

    (1987)
  • H. Bieth et al.

    J. Inorg. Biochem.

    (1990)
  • A. Sabatini et al.

    Talanta

    (1974)
  • M.J. Berridge et al.

    Nature

    (1984)
  • M.J. Berridge et al.

    Nature

    (1984)
  • M.J. Berridge

    Biochem. J.

    (1984)
  • M.J. Berridge et al.

    Nature

    (1989)
  • M.J. Berridge

    JAMA

    (1989)
There are more references available in the full text version of this article.

Cited by (15)

  • Carbohydrates as ligands: Coordination equilibria and structure of the metal complexes

    2000, Coordination Chemistry Reviews
    Citation Excerpt :

    A polysaccharide–iron complex named ‘Nifrex’ obtained from Fe(III)-chloride and Glc is also being used for treatment of iron deficiency anaemia [85,86]. There are many experiments in progress to develop other sugar type ligands like the l-idopyranosiduronic acid — containing oligosaccharides (Sarkar et al. [16]), or modified inositols (Hegetschweiler et al., [39] and Spiess et al. [87,88]). The Zn(II)–HyA complex has been patented and used as a medicine for the treatment of crural ulcer, decubitus and primarily non-healing wounds [89].

View all citing articles on Scopus
View full text